entity

CTMC

Also known as: Cell Therapy Manufacturing Center

Facts (9)

Sources

New cell therapy model accelerates cancer treatment development drugtargetreview.com Drug Target Review Feb 10, 2025 9 facts

referenceCTMC is a joint venture between Resilience and MD Anderson Cancer Center, established to accelerate patient access to cell therapies by bridging development and manufacturing with MD Anderson’s clinical trial capabilities.

measurementCTMC has operated for two and a half years without any instances of therapy mix-ups, a success attributed by Bock to the use of digital infrastructure to ensure the correct therapy reaches the correct patient.

referenceThe CTMC (Cell Therapy Manufacturing Center) model integrates industrial manufacturing capacity directly alongside clinical facilities to allow biotech companies to focus on scientific development rather than logistical concerns.

claimCTMC utilizes an industrial cell therapy manufacturing facility located adjacent to major patient centers, specifically MD Anderson and the Texas Medical Center.

claimCTMC operates an ecosystem that integrates patients, scientists, manufacturing technologies, and physicians in a single space to foster collaboration and provide readily available resources.

claimJason Bock, the co-founder and CEO of CTMC, advocates for a model of patient-adjacent manufacturing where industrial cell therapy manufacturing facilities are integrated with large medical centers.

claimJason Bock, PhD, is the co-founder and CEO of CTMC and has over 20 years of experience in innovative biologics development and commercialisation.

claimBock states that the CTMC model saves time and resources for biotech companies by coordinating logistical aspects of clinical trials, leading to more efficient capital use.

claimBiotech companies can utilize CTMC’s existing resources and access patient populations to accelerate the production and market entry of new cancer therapies.